Medical Grade Biopolymers Market Research Report - Segmentation by Type (Polycaprolactone (PCL), Polyglycolic Acid (PGA), Polyhydroxyalkanoates (PHA), Polylactic Acid (PLA), Others); Application (Devices, Implants, Disposables, Packaging, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15121
Format:
Region: Global
Chapter 1. MEDICAL GRADE BIOPOLYMERS MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. MEDICAL GRADE BIOPOLYMERS MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. MEDICAL GRADE BIOPOLYMERS MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. MEDICAL GRADE BIOPOLYMERS MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. MEDICAL GRADE BIOPOLYMERS MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. MEDICAL GRADE BIOPOLYMERS MARKET– By Type
6.1. Polycaprolactone (PCL)
6.2. Polyglycolic Acid (PGA)
6.3. Polyhydroxyalkanoates (PHA)
6.4. Polylactic Acid (PLA)
6.5. Others
Chapter 7. MEDICAL GRADE BIOPOLYMERS MARKET– By Application
7.1. Devices
7.1.1. Surgical Instruments
7.1.2. Diagnostic Equipment
7.1.3. Others
7.2. Implants
7.2.1. Orthopedic Implants
7.2.2. Electronic Implants
7.2.3. Dental Implants
7.3. Disposables
7.4. Packaging
7.5. Others
Chapter 8. MEDICAL GRADE BIOPOLYMERS MARKET – By Region
8.1. North America
8.2. Europe
8.3.The Asia Pacific
8.4.Latin America
8.5. Middle-East and Africa
Chapter 9. MEDICAL GRADE BIOPOLYMERS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1. BASF SE (Germany)
9.2. NatureWorks LLC (United States)
9.3. Evonik Industries AG (Germany)
9.4. DSM N.V. (Netherlands)
9.5. Bayer MaterialScience LLC (Germany)
9.6. DuPont de Nemours, Inc. (United States)
9.7. Corbion N.V. (Netherlands)
9.8. Galatea Surgical, Inc. (United States)
9.9. The Lubrizol Corporation (United States)
9.10. Foster Corporation (United States)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
Global Medical Grade Biopolymers Market is estimated to be worth USD 4.98 Billion in 2022 and is projected to reach a value of USD 9.22 Billion by 2030, growing at a CAGR of 8.0% during the forecast period 2023-2030.
The Global Medical Grade Biopolymers Market Drivers are the Growing Utilization of Protein-Based Biopolymers in Biomedical Applications and the Rising Adoption of Chitosan Biopolymers in Medical Applications.
Based on the Type, the Global Medical Grade Biopolymers Market is segmented into Polycaprolactone (PCL), Polyglycolic Acid (PGA), Polyhydroxyalkanoates (PHA), Polylactic Acid (PLA), and Others.
The United States is the most dominating country in the region of North America for the Global Medical Grade Biopolymers Market
BASF SE, NatureWorks LLC, and Evonik Industries AG are the leading players in the Global Medical Grade Biopolymers Market.
